INDICATIONS AND USAGE
To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Treatment
Doxycycline hyclate tablets are indicated for the treatment of following infections:
Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae .
Respiratory tract infections caused by Mycoplasma pneumoniae .
Lymphogranuloma venereum caused by Chlamydia trachomatis .
Psittacosis (ornithosis) caused by Chlamydophila psittaci .
Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence.
Inclusion conjunctivitis caused by Chlamydia trachomatis .
Uncomplicated urethral, endocervical, or rectal infections in adults caused by Chlamydia trachomatis .
Nongonococcal urethritis caused by Ureaplasma urealyticum .
Relapsing fever due to Borrelia recurrentis .
Doxycycline hyclate tablets are also indicated for the treatment of infections caused by the following gram-negative microorganisms:
Chancroid caused by Haemophilus ducreyi .
Plague due to Yersinia pestis .
Tularemia due to Francisella tularensis.
Cholera caused by Vibrio cholerae.
Campylobacter fetus infections caused by Campylobacter fetus .
Brucellosis due to Brucella
species (in conjunction with streptomycin).
Bartonellosis due to Bartonella bacilliformis.
Granuloma inguinale caused by Klebsiellagranulomatis.
Because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended.
Doxycycline hyclate tablets are indicated for treatment of infections caused by the following gram-negative bacteria, when bacteriologic testing indicates appropriate susceptibility to the drug:
Escherichia coli.
Enterobacter aerogenes .
Shigella
species.
Acinetobacter
species.
Respiratory tract infections caused by Haemophilus influenzae .
Respiratory tract and urinary tract infections caused by Klebsiella species.
Doxycycline hyclate tablets are indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:
Upper respiratory infections caused by Streptococcus pneumoniae .
Anthrax due to Bacillus anthracis , including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis .
When penicillin is contraindicated, doxycycline hyclate tablets are an alternative drug in the treatment of the following infections:
Uncomplicated
gonorrhea caused by Neisseria gonorrhoeae .
Syphilis
caused by Treponema pallidum.
Yaws caused by Treponema pallidum subspeciespertenue .
Listeriosis
due to Listeria monocytogenes .
Vincent's
infection caused by Fusobacterium fusiforme .
Actinomycosis
caused by Actinomyces israelii .
Infections
caused by Clostridium species.
In acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides.
In severe acne, doxycycline may be useful adjunctive therapy.
Prophylaxis:
Doxycycline hyclate tablets are indicated for the prophylaxis of malaria due to Plasmodium falciparum in short- term travelers (<4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains. (See
DOSAGE AND ADMINISTRATION
section and
Information for Patients
subsection of the PRECAUTIONS section).